Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs

References

• World Health Organisation. The world health report 2001: new understanding, new hope. World Health Organisation, Geneva 2001
   Google Scholar
• World Health Organisation. Reducing risks: promoting healthy life. World health report 2002. World Health Organisation, Geneva 2002
   Google Scholar
• Üstun T B, Ayuso-Mateos J L, Chatterji S, Mathers C, Murray C JL. Global burden of depressive disorders in the year 2000. Br J Psychiatry 2004; 184: 386–392
   PubMed Web of Science ®Google Scholar
• Kessler R, McGonagle K, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51: 8–19
   PubMed Web of Science ®Google Scholar
• Wittchen H U, Jacobi F. Size and burden of mental disorders in Europe—a critical review and appraisal of 27 studies. Eur Neuropharmacol 2005; 15: 357–376
   PubMed Web of Science ®Google Scholar
• WHO International Consortium in Psychiatric Epidemiology. Cross-national comparisons of the prevalences and correlates of mental disorders. Bull World Health Org 2000; 78: 413–426
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Prevention of mental disorders: effective interventions and policy options: a report of the World Health Organisation Department of Mental Health and Substance Abuse; in collaboration with the Prevention Research Centre of the Universities of Nijmegen and Maastricht. WHO, GenevaSwitzerland 2004, Available at: http://www.who.int/mental_health/evidence/en/prevention_of_mental_disorders_sr.pdf (accessed 5 October 2006)
   Google Scholar
• World Health Organisation. Promoting mental health: concepts, emerging evidence, practice: a report from the World Health Organisation, Department of Mental Health and Substance Abuse; in collaboration with the Victorian Health Promotion Foundation and the University of Melbourne. WHO, GenvaSwitzerland 2004, Available at: http://www.who.int/mental_health/evidence/en/promoting_mhh.pdf (accessed 5 October 2006)
   Google Scholar
• International Labour Organisation (ILO). Mental health in the workplace. ILO, Geneva 2000
   Google Scholar
• Anderson P, Holder H. Alcohol use disorders. Prevention of mental disorders: an overview on evidence-based strategies and programs, C Hosman, E Jané-Llopis, S Saxena. Oxford University Press, Oxford, in press
   Google Scholar
• Ezzati M, Rodgers A, Lopez A D, Vender Hoorn S, Murray C JL. Mortality and burden of disease attributable to individual risk factors. Comparative quantification of health risks: global and regional burden of disease due to selected major risk factors, M Ezzati, A D Lopez, A Rodgers, C JL Murray. World Health Organisation, Geneva 2004; 2141–2165
   Google Scholar
• Rehm J, Room R, Monteiro M, . Alcohol use. Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors, M Ezzati, A D Lopez, A Rodgers, C JL and Murray, et al. World Health Organisation, Geneva 2004; 1: 959–1108
   Google Scholar
• Anderson P, Baumberg B. Alcohol in Europe: a public health perspective. Institute of Alcohol Studies, London 2006
   Google Scholar
• Merikangas K, Mehta R, Molnar B, et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the international consortium in psychiatric epidemiology. Addict Behav 1998; 23: 893–907
   PubMed Web of Science ®Google Scholar
• Rohde P, Lewinsohn P M, Seeley J R. Comorbidity of unipolar depression: II. Comorbidity with other mental disorders in adolescents and adults. J Abnorm Psychol 1991; 100: 214–222
   PubMed Web of Science ®Google Scholar
• Nurcombe B. The evolution and validity of the diagnosis of major depression in childhood and adolescence. Developmental perspectives on depression: Rochester Symposium on Developmental Psychopathology, D Cicchetti, S Toth. University of Rochester, Rochester, NY 1992; 1–27
   Google Scholar
• Research in mood disorders: an update, H Hippius, C N Stefanis, F Miller-Sspahn. Hogrefe & Huber Publishers, GoettingenGermany 1994; 1: 1–16, Psychiatry in Progress Series
   Google Scholar
• Hammen C. Depression. Psychology Press, Taylor & Francis, California 1997
   Google Scholar
• Schoenborn C A, Horm S. Negative moods as correlates of smoking and heavier drinking: implications for health promotion. Adv Data 1993; 4(236)1–16
   Google Scholar
• Kessler R, Nelson C, McGonagle K, Edlund M, Frank R, Leaf P. The epidemiology of co-occurring addictive and mental disorders: implications for prevention and service utilization. Am J Orthopsychiatry 1996; 66: 17–31
   PubMed Web of Science ®Google Scholar
• Kessler R, Crum R, Warner L, Nelson C, Schulenberg J, Anthony J. Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey. Arch Gen Psychiatry 1997; 54: 313–321
   PubMed Web of Science ®Google Scholar
• Book S W, Randall C L. Social anxiety disorder and alcohol use. Alcohol Res Health 2002; 26: 130–135
   Google Scholar
• Grant B F, Stinson F S, Dawson D A, Chou P S, Ruan W J, Pickering R P. Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States. Arch Gen Psychiatry 2004; 61: 361–368
   PubMed Web of Science ®Google Scholar
• Farrell M, Howes S, Taylor C, et al. Substance misuse and psychiatric comorbidity: an overview of the OPCS National Psychiatric Morbidity Survey. Addict Behav 1998; 23: 909–918
   PubMed Web of Science ®Google Scholar
• Weaver T, Rutter D, Madden P, Ward J, Stimson G, Renton A. Results of a screening survey for co-morbid substance misuse amongst patients in treatment for psychotic disorders: prevalence and service needs in an inner London borough. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 399–406
   PubMed Web of Science ®Google Scholar
• Farris C, Brems C, Johnson M E, Wells R, Burns R, Kletti N. A comparison of schizophrenic patients with or without coexisting substance use disorder. Psychiatr Q 2003; 74: 205–222
   PubMed Web of Science ®Google Scholar
• World Health Organisation (WHO). The ICD-10 classification of mental and behavioural disorders: clinical descriptions and diagnostic guidelines. WHO, Geneva 1992
   Google Scholar
• Kessler R, Tat Chiu W, Demler O, Walters E. Prevalence, severity and comorbidity of 12-Month DSM-IV Disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 2005; 62: 617–627
   PubMed Web of Science ®Google Scholar
• Grant B F, Stinson F S, Dawson D A, et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry 2004; 61: 807–816
   PubMed Web of Science ®Google Scholar
• Grant B F, Hasin D S, Chou S P, Stinson F S, Dawson D A. Nicotine dependence and psychiatric disorders in the United States. Arch Gen Psychiatry 2004; 61: 1107–1115
   PubMed Web of Science ®Google Scholar
• Kandel D B, Huang F Y, Davies M. Comorbidity between patterns of substance use dependence and psychiatric syndromes. Drug Alcohol Depend 2001; 64: 233–241
   PubMed Web of Science ®Google Scholar
• Farrell M, Howes S, Bebbington P, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity. Br J Psychiatry 2001; 179: 432–437
   PubMed Web of Science ®Google Scholar
• Offord D, Boyle M, Campbell D, et al. One-year prevalence of psychiatric disorder in Ontarians 15-64 years of age. Can J Psychiatry 1996; 41: 559–563
   PubMed Web of Science ®Google Scholar
• Alonso J, Angermeyer M, Bernert S, et al. The ESEMeD/MHEDEA 2000 investigators. 12-month comorbidity patterns and associated factors in Europe: results from the European Study of the Epidemiology of Mental Disorders (ESEMeD) project. Acta Psychiatr Scand 2004; 109(Suppl. 420)28–37
   Google Scholar
• Narrow W, Rae W, Robins L, Regier D. Revised prevalence estimates of mental disorders in the United States. Arch Gen Psychiatry 2002; 59: 115–123
   PubMed Web of Science ®Google Scholar
• Kessler R C, Berglund P, Demler O, et al. The epidemiology of major depressive disorder. Results from the National Comorbidity Survey Replication (NSR-R). JAMA 2003; 289: 3095–3106
   PubMed Web of Science ®Google Scholar
• De Graaf R, Bijl R, Smit F, Vollebergh W, Spijker J. Risk factors for 12-month comorbidity of mood, anxiety, and substance use disorders: findings from the Netherlands Mental Health Survey and Incidence Study. Am J Psychiatry 2002; 159: 620–629
   PubMed Web of Science ®Google Scholar
• Watkins K E, Burnam A, Kung F Y, Paddock S. A national survey of care for persons with co-occurring mental and substance use disorders. Psychiatr Serv 2001; 52: 1062–1069
   PubMed Web of Science ®Google Scholar
• Kessler R, Berglund P, Glantz M, . Estimating the prevalance and correlates of serious mental illness in community epidemiological surveys. Mental health United States 2002, R W Manderscheid, M Henderson, et al. US Department of Health and Human Services, Substance Abuse and Mental Health Services Administration Center for Mental Health Services, Rockville, MD 2002, Chapter 12
   Google Scholar
• Kessler R. The epidemiology of dual diagnosis. Biol Psychiatry 2004; 456: 730–737
   Google Scholar
• Teesson M, Hall W, Lynskey M, Degenhardt L. Alcohol- and drug-use disorders in Australia: implications of the National Survey of Mental Health and Wellbeing. Aust NZ J Psych 2000; 34: 206–213
   PubMed Web of Science ®Google Scholar
• Degenhardt L, Hall W, Lyndskey M. The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 219–227
   PubMed Web of Science ®Google Scholar
• Regier D A, Narrow W E, Rae D S. The epidemiology of anxiety disorders. J Psychiatr Res 1990; 24: 3–14
   PubMed Web of Science ®Google Scholar
• John U, Meyer C, Rumpf H J, Hapke U. Smoking, nicotine dependence and psychiatric comorbidity—a population-based study including smoking cessation after three years. Drug Alcohol Depend 2004; 76: 287–295
   PubMed Web of Science ®Google Scholar
• Zilberman M L, Tavares H, Blume S B, el-Guebaly N. Substance use disorders: sex differences and psychiatric comorbidities. Can J Psychiatry 2003; 48: 5–13
   PubMed Web of Science ®Google Scholar
• Poulin C, Hand D, Boudreau B, Santor D. Gender differences in the association between substance use and elevated depressive symptoms in a general adolescent population. Addiction 2005; 100: 525–535
   PubMed Web of Science ®Google Scholar
• Ferdinand R, Sondeijker F, van der Ende J, Selten J P, Huizink A, Verhulst F. Cannabis use predicts future psychotic symptoms, and vice versa. Addiction 2005; 100: 612–618
   PubMed Web of Science ®Google Scholar
• Blakely T, Hales S, Kieft C, Wilson N, Woodward A. Distribution of risk factors by poverty. Comparative quantification of health risks: global and regional burden of disease due to selected major risk factors, M Ezzati, A D Lopez, A Rodgers, C JL Murray. World Health Organisation, Geneva 2004; 1941–2128
   Google Scholar
• Hyman S, Chisholm D, Kessler R, Patel V, Whiteford H. Mental disorders. Disease control priorities in developing countries, 2nd edn, D T Jamison, J G Breman, A R Measham, et al. Oxford University Press, Oxford 2006; 605–627
   Google Scholar
• Bakken K, Landheim A S, Vaglum P. Primary and secondary substance misusers: do they differ in substance-induced and substance-independent mental disorders?. Alcohol Alcohol 2003; 38: 54–59
   PubMed Web of Science ®Google Scholar
• Phillips P, Johnson S. How does drug and alcohol misuse develop among people with psychotic illness? A literature review. Soc Psychiatry Psychiatr Epidemiol 2001; 36: 269–276
   PubMed Web of Science ®Google Scholar
• Gratzer D, Levitan R D, Sheldon T, Toneatto T, Rector N A, Goering P. Lifetime rates of alcoholism in adults with anxiety, depression, or co-morbid depression/anxiety: a community survey of Ontario. J Affect Disord 2004; 79: 209–215
   PubMed Web of Science ®Google Scholar
• Arsenault L, Cannon M, Witton J, Murray R. Casual association between cannabis and psychosis: examination of the evidence. Br J Psychiatry 2004; 184: 110–117
   PubMed Web of Science ®Google Scholar
• Breslau N, Novak S, Kessler R. Psychiatric disorders and stages of smoking. Biol Psychiatry 2004; 55: 69–76
   PubMed Web of Science ®Google Scholar
• Mueser K T, Drake R E, Wallach M A. Dual diagnosis: a review of etiological theories. Addict Behav 1998; 23: 717–734
   PubMed Web of Science ®Google Scholar
• World Health Organisation. Mental health declaration for Europe: facing challenges, building solutions. World Health Organisation Regional Office for Europe, Copenhagen 2005, Available at: http://www.euro.who.int/document/mnh/edoc06.pdf (accessed 5 October 2006)
   Google Scholar
• World Health Organisation. Mental health action plan for Europe: facing challenges, building solutions. World Health Organisation Regional Office for Europe, Copenhagen 2005
   Google Scholar
• Kessler R C, Price R H. Primary prevention of secondary disorders: a proposal and agenda. Am J Commun Psychol 1993; 21: 607–633
   PubMed Web of Science ®Google Scholar
• Coie J D, Watt N F, West S G, et al. The science of prevention. Am Psychol 1993; 48: 1013–1022
   PubMed Web of Science ®Google Scholar
• Hoefnagels C, Mudde A. Mass media and disclosures of child abuse in the perspective of secondary prevention: putting ideas into practice. Child Abuse Neglect 2000; 24: 1091–1101
   PubMed Web of Science ®Google Scholar
• Yoshikawa H. Prevention as cumulative protection: effects of early family support and education on chronic delinquency and its risks. Psychol Bull 1994; 115: 28–54
   PubMed Web of Science ®Google Scholar
• Hill S Y, Locke J, Lowers L, Connolly J. Psychopathology and achievement in children at high risk for developing alcoholism. J Am Acad Child Adolesc Psychiatry 1999; 38: 883–891
   PubMed Web of Science ®Google Scholar
• Shinn M, Toohey S M. Refocusing on primary prevention. Prev Treat 2001; 4
   Google Scholar
• Olds D. The prenatal early infancy project. 14 ounces of prevention: a casebook for practitioners, R H Price, E L Cowen, R P Lorian, J Ramos-McKay. American Psychological Association, Washington, DC 1988; 9–23
   Google Scholar
• Olds D. The prenatal early infancy project: preventing child abuse and neglect in the context of promoting maternal and child health. Child abuse: new directions in prevention and treatment across the lifespan, D A Wolfe, R J McMahon, R D Peters. Sage Publications, Inc., Thousand Oaks, CA 1997; 130–154
   Google Scholar
• Olds D. The prenatal/early infancy project: fifteen years later. Primary prevention works, G W Albee, T P Gullotta. Sage Publications, Inc., Thousand Oaks, CA 1997; 41–67
   Google Scholar
• Olds D L. The prenatal/early infancy project: a strategy for responding to the needs of high-risk mothers and their children. Prev Human Serv 1989; 7: 59–87
   Google Scholar
• Schweinhart L J, Weikart D P. High/Scope Perry Preschool Program effects at age twenty-seven. Social programs that work, J Crane. Russell Sage Foundation, New York, NY 1998; 148–162
   Google Scholar
• Saxena S, Jané-Llopis E, Hosman C. Prevention of mental and behavioural disorders: implications for policy and practice. World Psychiatry 2006; 5: 5–14
   PubMed Web of Science ®Google Scholar
• Jané-Llopis E, Hosman C, Jenkins R, Anderson P. Predictors of efficacy in depression prevention. Meta-analysis. Br J Psychiatry 2003; 183: 384–397
   PubMed Web of Science ®Google Scholar
• Price R H, Van Ryn M, Vinokur A D. Impact of a preventive job search intervention on the likelihood of depression among the unemployed. J Health Social Behav 1992; 33: 158–167
   PubMed Web of Science ®Google Scholar
• Dhossche D M, Meloukheia A M, Chakravorty S. The association of suicide attempts and comorbid depression and substance abuse in psychiatric consultation patients. Gen Hosp Psychiatry 2000; 22: 281–288
   PubMed Web of Science ®Google Scholar
• Kay-Lambkin F, Baker A, Lewin T. The ‘comorbidity roundabout’: a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems. Drug Alcohol Rev 2004; 23: 407–423
   PubMed Web of Science ®Google Scholar
• Anderson P, Laurant M, Kaner E, Grol R, Wensing M. Engaging general practitioners in the management of alcohol problems: results of a meta-analysis. J Stud Alcohol 2004; 65: 191–199
   PubMed Web of Science ®Google Scholar
• Anderson P, Jané-Llopis E. How can we increase the involvement of primary care in the treatment of tobacco dependence? A meta-analysis. Addiction 2004; 99: 299–313
   PubMed Web of Science ®Google Scholar
• Van Weel-Baumgarten E, Jané-Llopis E, Mynors-Wallis L, Anderson P. Prevention of mental illness in primary care. The Imhpa manual and the general practitioner's role [Editorial]. Eur J Gen Pract 2005; 11: 92–93
   PubMedGoogle Scholar
• Mynors-Wallis L, DaviesGath D H, Day A, Baker F. Randomised controlled trial of problem-solving treatment, antidepressant medication and combined treatment for major depression in primary care. BMJ 2000; 320: 26–30
   PubMed Web of Science ®Google Scholar
• European Community (EC). Green Paper improving the mental health of the population. Towards a strategy on mental health for the European Union. European Communities, Luxembourg 2005, Available at : http://europa.eu.int/comm/health/ph_determinants/life_style/mental/green_paper/consultation_en.htm (accessed 5 October 2006)
   Google Scholar
• Bijl R V, Ravelli A, van Zessen G. Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 1998; 33: 587–595
   PubMed Web of Science ®Google Scholar
• Henderson S, Andrews G, Hall W. Australia's mental health: an overview of the general population survey. Aust NZJ Psychiatry 2000; 34: 197–205
   PubMed Web of Science ®Google Scholar